Comparative characteristics of cytokines in BAL fluid in occupational lung diseases and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006
Level of cytokines in bronchoalveolar lavage fluid (BALF) in patients with professional lung diseases and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001
Sampling the lung fluids: peripheral biomarkers Source: Annual Congress 2007 - Pulmonary biomarkers in COPD Year: 2007
Airway dendritic cell phenotypes in inflammatory diseases of the human lung Source: Eur Respir J 2007; 30: 878-886 Year: 2007
Redox status, metals-microelements and cytokines in blood of bronchial asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 680s Year: 2006
Phenotypic analysis of lymphocytes in bronchoalveolar lavage fluid and peripheral blood from patients with chronic inflammatory lung diseases Source: Eur Respir J 2004; 24: Suppl. 48, 534s Year: 2004
Carbonylated proteins in BAL of patients with interstititial lung diseases Source: Eur Respir J 2005; 26: Suppl. 49, 344s Year: 2005
Biological markers of inflammation in asthma in children - eosinophils in sputum and ECP in peripheral blood Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005
Cellular changes in BAL fluid may reflect immunity in patients with lung cancer Source: Annual Congress 2005 - Various scenarios produced by cancer and lung transplantation: dialogue between oncogenesis and immunosuppression Year: 2005
Role of BALF in differential diagnosis of smoking related interstitial lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 828s Year: 2006
Activation of MMP-9 in BAL is increased in COPD exacerbation independently of smoking, lung function, microbiology and treatment Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases Year: 2014
Eosinophils in peripheral blood are associated with eosinophils in sputum, BAL, and bronchial biopsies in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004
Systemic inflammation, blood eosinophils count and lung function in COPD patients Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017
Main features of cytokine profile in serum and bronchoalveolar lavage fluid in patients with recurrent sarcoidosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
Changes of BAL findings as no progression marker in idiopathic pulmonary fibrosis (IPF) patients treated with IFN-g Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006
Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005
Sputum protein profiles for monitoring lung pathophysiology in chronic lung diseases Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Can blood eosinophils predict sputum eosinophils in stable COPD? Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015
Mechanisms of impaired immune surveillance in lower airways of smokers. Data from bronchoalveolar lavage (BAL) harvested in selected interstitial lung diseases (ILDs) and control group Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease Year: 2011